Mayo Clinic deploys Nvidia systems to build scalable AI infrastructure for multimodal and generative foundation models in pathology, drug discovery, and precision medicine.

Precision medicine promises to tailor health care to the individual. But what happens when entire communities are left out of ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

Topline data were announced from a phase 3 clinical program evaluating anselamimab in patients with Mayo stages 3a and 3b light chain (AL) amyloidosis.

In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be ...

This month: good news for java lovers, a how-to guide on migraine and CVD, medically tailored meals for HF, and more.

In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis ...

In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...